15 February 2024 - The EMA and the Heads of Medicines Agencies have launched two public electronic catalogues: one for ...
23 June 2023 - Real world evidence from studies led by regulators can complement evidence from other sources including clinical trials. ...
28 March 2023 - DARWIN EU, the Data Analysis and Real World Interrogation Network, has accomplished its first year of establishment. ...
2 March 2023 - Real world data are advocated as an alternative approach to randomised clinical trials for closing knowledge gaps ...
23 November 2022 - EMA has selected the first set of data partners to collaborate with DARWIN EU, the Data Analysis ...
10 October 2022 - EMA and the Heads of Medicines Agencies in the EU Member States are moving ahead with ...
20 July 2022 - EMA has endorsed a joint statement calling for international collaboration to enable the generation and use ...
20 June 2022 - Lessons learned from international collaboration on observational research during the pandemic were highlighted during the latest global ...
9 February 2022 - EMA is initiating today the establishment of the Coordination Centre for the Data Analysis and Real ...
24 November 2021 - Enabling the use of real world evidence and establishing its value for regulatory decision-making on the development, ...
14 September 2021 - The EMA has identified a need for more consistency in how real world evidence is submitted. ...
4 June 2021 - Medicines regulators from around the world discussed the importance of global collaboration and information sharing in relation ...
8 February 2021 - In a dedicated COVID-19 workshop, convened under the umbrella of the International Coalition of Medicines Regulatory Authorities, ...
23 October 2020 - Medicines regulators from around the world discussed their experiences with supporting and assessing real-world evidence to facilitate ...
31 July 2020 - Vaccines surveillance and vigilance, collaboration on pregnancy studies and building international patient cohorts were the main ...